AMZE vs BMY · rev $2.0M vs P/E 17, rev $24.46B
Amaze Holdings Inc (AMZE) versus Bristol-Myers Squibb Company (BMY) — a side-by-side from cached financials, not a winner call.
Amaze Holdings Inc (AMZE) is a beverages - wineries & distilleries company listed on US.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Christopher S. Boerner Ph.D..
Latest reported AMZE revenue for 2025-12-31 was $2.0M. Net income was -$55.2M. Revenue was up 557.8% from 2024-12-31 to 2025-12-31. AMZE currently screens at market cap $0.
Latest reported BMY revenue for 2026-06-30 was $24.46B. Net income was $5.99B. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
AMZE currently screens at market cap $0. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Not investment advice. Open the AMZE and BMY stock pages for the full models.
Not investment advice.